| ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.305 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.305 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
1.305 |
Evidence |
|
| INSL3 |
JAK3: Tyrosine-protein kinase JAK3 |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.305 |
Evidence |
|
| IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.305 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.305 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
BMX |
IPI00514142 |
1.305 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
1.305 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.305 |
Evidence |
|
| SERPINF1 |
SERPINF1, PEDF: Pigment epithelium-derived factor precursor |
GZMB |
Endogenous granzyme B |
1.305 |
Evidence |
|
| AHR |
AHR: Aryl hydrocarbon receptor precursor |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
1.305 |
Evidence |
|
| CIITA |
CIITA, MHC2TA: MHC class II transactivator |
THOC1 |
THOC1, HPR1: THO complex subunit 1 |
1.305 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
1.305 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.305 |
Evidence |
|
| CD40LG |
CD40LG, CD40L, TNFSF5, TRAP: CD40 ligand |
TNFRSF10C |
TNFRSF10C, DCR1, UNQ321/PRO366, LIT, TRAILR3, TRID: Tumor necrosis factor recept |
1.305 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
SH2D2A |
SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A |
1.305 |
Evidence |
|
| IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
IL2 |
IL2: Interleukin 2 |
1.305 |
Evidence |
|
| FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.305 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
GNAI2 |
Galphai2 protein |
1.305 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.305 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.305 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.305 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.305 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
1.305 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.305 |
Evidence |
|